---

Joseph Schlessinger

William H. Prusoff Professor and Chairman of the Pharmacology Department, Yale School of Medicine; Director, Yale Cancer Biology Institute

“The focus of my research during the past 12 months has been the identification of the ligand for the orphan receptor tyrosine kinase (RTK) ALK, and elucidation of the mechanism of action of a therapeutic antibody using structural and biochemical studies, as well as exploration of signaling pathways that are aberrantly activated by oncogenic RTKs in cancer,” says Joseph.

---

Part of the Power List 2016

The Top 100

The nominations are in and after considerable debate and analysis from our judging panel, we present The Power List 2016 – our second foray into the Top 100 most influential people in the world of drug development and manufacture.

Go to The Power List 2016